Home Breakthrough: India starts Phase 3 trial for tetravalent dengue vaccine India begins Phase 3 clinical trial with 1st indigenous dengue vaccine

India begins Phase 3 clinical trial with 1st indigenous dengue vaccine

This landmark trial aims to evaluate the efficacy of DengiAll, India’s indigenous tetravalent dengue vaccine developed by Panacea Biotec

This landmark trial aims to evaluate the efficacy of DengiAll, India’s indigenous tetravalent dengue vaccine developed by Panacea Biotec

Prasad Sawant
Prasad Sawant
Prasad Sawant
Latest posts by Prasad Sawant (see all)

    BOOKS